hsa-mir-3197: Hsa-mir-3197 is a microRNA (miRNA) that has been identified in various studies. It has been found to be one of the microRNAs regulated by hsa_circRNA_000957 and hsa_circRNA_101798, with 29 and 4 related target genes, respectively [PMC9451056]. The expression of hsa-mir-3197 has been evaluated in different contexts. For example, it was found to be significantly downregulated in the plasma of patients with COVID-19 [PMC9346380]. In patients with autism spectrum disorder (ASD), hsa-mir-3197 was identified as one of the top three downregulated miRNAs [PMC9000903]. Hsa-mir-3197 was also evaluated as one of the miRNAs encoded by chromosome 21 [PMC5863254]. Additionally, it has been regulated by TNFRSF13C and associated with intrahepatic cholangiocarcinoma [PMC7679428] [PMC7257878]. The expression levels of hsa-mir-3197 have also been found to be altered in different conditions. For example, it was downregulated by L. crispatus and upregulated in patients with intrahepatic cholangiocarcinoma [PMC10054151] [PMC7257878]. Hsa-mir-3197 is among the miRNAs associated with overall survival in patients with intrahepatic cholangiocarcinoma [PMC7257878]. It is worth noting that hsa-mir-3197 is just one among several miRNAs that have been identified and studied in various contexts.